share_log

HC Wainwright & Co. Maintains Buy on Galera Therapeutics, Lowers Price Target to $6

HC Wainwright & Co. Maintains Buy on Galera Therapeutics, Lowers Price Target to $6

HC Wainwright & Co.维持对Galera Therapeutics的买入,将目标价下调至6美元
Benzinga ·  2023/03/22 06:22

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Galera Therapeutics (NASDAQ:GRTX) with a Buy and lowers the price target from $10 to $6.

HC Wainwright&Co.分析师Raghuram Selvaraju坚持认为Galera Treateutics(纳斯达克:GRTX)为买入,并将目标价从10美元下调至6美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发